Photocure ASA – Annual general meeting held
Oslo, Norway, 28 April 2022: Photocure ASA (OSE: PHO), held its annual general meeting on 28 April 2022 at 17:00 hours (CET).
All proposals were resolved as presented in the notice convening the annual general meeting dated 7 April 2022, as further set out in the minutes from the general meeting attached hereto.
For further information, please contact:
CFO Erik Dahl
Tel: + 47 450 55 000
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.